Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases

Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works

Hydrogen peroxide mediates amyloid β protein toxicity

Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · see citing works

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works

Role of Genes and Environments for Explaining Alzheimer Disease

Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · see citing works

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · see citing works

The Clinical Diagnosis of Alzheimer's Disease

Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C. S., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,416 · see citing works

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · see citing works

Parkinson's disease

Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,305 · see citing works

Genomic imprinting in mammalian development: a parental tug-of-war

Moore, T. (1991) · Trends in Genetics · doi:10.1016/0168-9525(91)90230-n · Cited by 1,281 · see citing works

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246 · see citing works

Cytochrome oxidase: an endogenous metabolic marker for neuronal activity

Wong-Riley, M. T. T. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90165-3 · Cited by 1,238 · see citing works

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · see citing works

[ ¹¹ C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · see citing works

A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.

Holt, I. J., Harding, A. E., Petty, R., & MORGAN-HUGHES, J. A. (1990) · PubMed · Cited by 996 · see citing works

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · see citing works

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · see citing works

Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease

Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907 · see citing works

Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 900 · see citing works

Alzheimer's Disease--Genotypes, Phenotype, and Treatments

Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 871 · see citing works

Dementia and Alzheimer Disease Incidence: A Prospective Cohort Study

Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., & Larson, E. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1737 · Cited by 806 · see citing works

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease

Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · see citing works

-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789 · see citing works

A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease

Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688 · see citing works

Untitled work

(1997) · PubMed · Cited by 645 · see citing works

Origin and functional consequences of the complex I defect in Parkinson's disease

Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638 · see citing works

Prediction of cognitive decline in normal elderly subjects with 2-[ ¹⁸ F]fluoro-2-deoxy- <scp>d</scp> -glucose/positron-emission tomography (FDG/PET)

de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629 · see citing works

Apolipoprotein E Type 4 Allele and Cerebral Glucose Metabolism in Relatives at Risk for Familial Alzheimer Disease

Small, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604 · see citing works

Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease

Mosconi, L., Pupi, A., & de Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 599 · see citing works

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · see citing works

Mitochondrial disease

Schapira, A. H. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68970-8 · Cited by 594 · see citing works

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication

Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556 · see citing works

Clearing the brain's amyloid cobwebs

Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541 · see citing works

Brain cytochrome oxidase in Alzheimer's disease

Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537 · see citing works

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

van der Walt, J. M., Nicodemus, K. K., Martin, E. R., Scott, W. K., NANCE, M. A., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K. E., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373937 · Cited by 537 · see citing works

Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease

Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531 · see citing works

Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education

Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafström, M., Holmen, K., Ericsson, K., Bäckman, L., Ahlbom, A., & Winblad, B. (1991) · Neurology · doi:10.1212/wnl.41.12.1886 · Cited by 525 · see citing works

Aging renders the brain vulnerable to amyloid β-protein neurotoxicity

Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520 · see citing works

Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham Study

Seshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489 · see citing works

GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers

Reiman, E. M., Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., Joshipura, K. D., Pearson, J. V., Hu-Lince, D., Huentelman, M. J., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.022 · Cited by 487 · see citing works

Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease

Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467 · see citing works

New Frontiers in Alzheimer's Disease Genetics

Tanzi, R. E., & Bertram, L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00476-7 · Cited by 464 · see citing works

Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463 · see citing works

Radical AGEing in Alzheimer's disease

Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93897-7 · Cited by 462 · see citing works

Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients

Shoffner, J. M., Brown, M. D., Torroni, A., Lott, M. T., Cabell, M. F., Mirra, S. S., Beal, M. F., Yang, C.-C., Gearing, M., Salvo, R., et al. (1993) · Genomics · doi:10.1006/geno.1993.1299 · Cited by 450 · see citing works

A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis

Fede, G. D., Catania, M., Morbin, M., Rossi, G., Suardi, S., Mazzoleni, G., Merlin, M., Gıovagnolı, A. R., Prioni, S., Erbetta, A., et al. (2009) · Science · doi:10.1126/science.1168979 · Cited by 415 · see citing works

A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia

Tomiyama, T., Nagata, T., Shimada, H., Teraoka, R., Fukushima, A., Kanemitsu, H., Takuma, H., Kuwano, R., Imagawa, M., Ataka, S., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21321 · Cited by 414 · see citing works

Heritability for Alzheimer’s disease: the study of dementia in Swedish twins

Gatz, M., Pedersen, N. L., Berg, S., Johansson, B., Johansson, K., Mortimer, J. A., Posner, S. F., Viitanen, M., Winblad, B., & Ahlbom, A. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.2.m117 · Cited by 413 · see citing works

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

Scheltens, P., Fox, N. C., Barkhof, F., & DeCarli, C. S. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00002-9 · Cited by 410 · see citing works

Common Kibra Alleles Are Associated with Human Memory Performance

Papassotiropoulos, A., Stephan, D. A., Huentelman, M. J., Hoerndli, F. J., Craig, D. W., Pearson, J. V., Huynh, K.-D., Brunner, F., Corneveaux, J. J., Osborne, D., et al. (2006) · Science · doi:10.1126/science.1129837 · Cited by 402 · see citing works

Risk of Dementia Among White and African American Relatives of Patients With Alzheimer Disease

Green, R. C. (2002) · JAMA · doi:10.1001/jama.287.3.329 · Cited by 391 · see citing works

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389 · see citing works

The dementias

Ritchie, K. A., & Lovestone, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11667-9 · Cited by 386 · see citing works

Genomic imprinting effects on brain development and function

Wilkinson, L. S., Davies, W., & Isles, A. R. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2235 · Cited by 373 · see citing works

Hippocampal hypometabolism predicts cognitive decline from normal aging

Mosconi, L., De Santi, S., Li, J., Tsui, W. H., Li, Y., Boppana, M., Laska, E., Rusinek, H., & de Leon, M. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.008 · Cited by 360 · see citing works

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease

Bosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348 · see citing works

Mechanisms of imprinting of the Prader-Willi/Angelman region

Horsthemke, B., & Wagstaff, J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32364 · Cited by 320 · see citing works

Marked changes in mitochondrial DNA deletion levels in Alzheimer brains

Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., Graham, B. H., & Wallace, D. C. (1994) · Genomics · doi:10.1006/geno.1994.1525 · Cited by 309 · see citing works

Essential role for Gab2 in the allergic response

Gu, H., Saito, K., Klaman, L. D., Shen, J., Fleming, T., Wang, Y., Pratt, J. C., Lin, G., Lim, B., Kinet, J., et al. (2001) · Nature · doi:10.1038/35084076 · Cited by 304 · see citing works

Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines

Trimmer, P. A., Swerdlow, R. H., Parks, J. K., Keeney, P. M., Bennett, J. P., Miller, S. W., Davis, R. E., & Parker, W. D. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7333 · Cited by 296 · see citing works

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer’s disease

Carrasquillo, M. M., Zou, F., Pankratz, V. S., Wilcox, S. L., Ma, L., Walker, L. P., Younkin, S. G., Younkin, C. S., Younkin, L. H., Bisceglio, G. D., et al. (2009) · Nature Genetics · doi:10.1038/ng.305 · Cited by 296 · see citing works

Positron emission tomography imaging in dementia

HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287 · see citing works

Cytochrome c oxidase is decreased in Alzheimer’s disease platelets

Cardoso, S. M., Proença, M. T., Santos, S., Santana, I., & Oliveira, C. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00033-2 · Cited by 281 · see citing works

Analysis of European mitochondrial haplogroups with Alzheimer disease risk

van der Walt, J. M., Dementieva, Y. A., Martin, E. R., Scott, W. K., Nicodemus, K. K., Kroner, C. C., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Small, G. W., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.04.051 · Cited by 280 · see citing works

Molecular genetics of Alzheimer’s disease

George‐Hyslop, P. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00301-7 · Cited by 276 · see citing works

Alzheimer's disease: Genetic aspects and associated clinical disorders

Heyman, A., William Ebomoyi, E., Hurwitz, B. J., Schmechel, D. E., Sigmon, A. H., Weinberg, T., Helms, M. J., & Swift, M. (1983) · Annals of Neurology · doi:10.1002/ana.410140503 · Cited by 272 · see citing works

Cybrids in Alzheimer's disease: a cellular model of the disease?

Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D. (1997) · Neurology · doi:10.1212/wnl.49.4.918 · Cited by 272 · see citing works

Untitled work

(2006) · PubMed · Cited by 269 · see citing works

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

Reiman, E. M., Uecker, A., Caselli, R. J., Lewis, S., Bandy, D., De Leon, M. J., De Santi, S., Convit, A., Osborne, D., Weaver, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440226 · Cited by 266 · see citing works

Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity

Cardoso, S. M., Santana, I. J., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 262 · see citing works

Cybrids in Alzheimer's disease: A cellular model of the disease?

Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260 · see citing works

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 256 · see citing works

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

Kennedy, A. M., Frackowiak, R. S. J., Newman, S. K., Bloomfield, P. M., Seaward, J., Roques, P., Lewington, G., Cunningham, V. J., & Rossor, M. N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11270-7 · Cited by 250 · see citing works

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90291-2 · Cited by 245 · see citing works

Resourceful imprinting

Constância, M., Kelsey, G., & Reik, W. (2004) · Nature · doi:10.1038/432053a · Cited by 242 · see citing works

Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration

Valla, J. E., Berndt, J. D., & Gonzalez-Lima, F. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04923.2001 · Cited by 237 · see citing works

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

Mosconi, L., Brys, M., Switalski, R., Mistur, R., Glodzik, L., Pirraglia, E., Tsui, W., De Santi, S., & de Leon, M. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705036104 · Cited by 237 · see citing works

Voxel-based analysis of PET amyloid ligand [ 11 C]PIB uptake in Alzheimer disease

Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M. H., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000240117.55680.0a · Cited by 227 · see citing works

Expanding the association between the <i>APOE</i> gene and the risk of Alzheimer's disease: possible roles for <i>APOE</i> promoter polymorphisms and alterations in <i>APOE</i> transcription

Laws, S. M., Hone, E., Gandy, S., & Martins, R. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01615.x · Cited by 223 · see citing works

Variability and validity of polymorphism association studies in Parkinson’s disease

Tan, E., Khajavi, M., Thornby, J. I., Nagamitsu, S., Jankovic, J. J., & Ashizawa, T. (2000) · Neurology · doi:10.1212/wnl.55.4.533 · Cited by 217 · see citing works

The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J

Brown, M. D., Starikovskaya, E. B., Derbeneva, O. A., Hosseini, S., Allen, J. C., Mikhailovskaya, I. E., Sukernik, R. I., & Wallace, D. C. (2002) · Human Genetics · doi:10.1007/s00439-001-0660-8 · Cited by 215 · see citing works

Presenilin, Notch, and the genesis and treatment of Alzheimer's disease

Selkoe, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211352598 · Cited by 202 · see citing works

Reduced platelet cytochrome c oxidase activity in Alzheimer's disease

Parker, W. D., Mahr, N., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., & Cullum, C. M. (1994) · Neurology · doi:10.1212/wnl.44.6.1086 · Cited by 199 · see citing works

Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice

Davies, W., Isles, A. R., Smith, R., Karunadasa, D. K., Burrmann, D., Humby, T., Ojarikre, O. A., Biggin, C., Skuse, D., Burgoyne, P. S., et al. (2005) · Nature Genetics · doi:10.1038/ng1577 · Cited by 192 · see citing works

Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease

Mosconi, L., Mistur, R., Switalski, R., Brys, M., Glodzik, L., Rich, K., Pirraglia, E., Tsui, W., De Santi, S., & de Leon, M. J. (2009) · Neurology · doi:10.1212/01.wnl.0000333247.51383.43 · Cited by 188 · see citing works

Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD

Pyle, A., Foltynie, T., Tiangyou, W., Lambert, C., Keers, S. M., Allcock, L. M., Davison, J., Lewis, S. J. G., Perry, R. H., Barker, R. A., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20417 · Cited by 176 · see citing works

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.

Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Pa, T., Krebs, C. T., Bennett, J. C., Parks, J. K., Swerdlow, R. H., et al. (2000) · PubMed · Cited by 176 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Schapira, A. H. V. (2007) · Cell Death &amp; Differentiation · doi:10.1038/sj.cdd.4402160 · Cited by 175 · see citing works

Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease

Carrieri, G., Bonafè, M., Luca, M. D., Rose, G., Varcasia, O., Bruni, A. C., Maletta, R., Nacmias, B., Sorbi, S., Corsonello, F., et al. (2001) · Human Genetics · doi:10.1007/s004390100463 · Cited by 169 · see citing works

Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL study

Cupples, L. A., Farrer, L. A., Sadovnick, A. S. D., Relkin, N. R., Whitehouse, P. J., & Green, R. C. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000132679.92238.58 · Cited by 166 · see citing works

Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

Valla, J., Schneider, L., Niedzielko, T., Coon, K. D., Caselli, R., Sabbagh, M. N., Ahern, G. L., Baxter, L., Alexander, G., Walker, D. G., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.10.004 · Cited by 159 · see citing works

Leber's hereditary optic neuropathy: A multifactorial disease

YEN, M., WANG, A., & Wei, Y. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.002 · Cited by 157 · see citing works

APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD

Geroldi, C., Pihlajamaki, M. M., Laakso, M. P., DeCarli, C. S., Beltramello, A., Bianchetti, A., Soininen, H. S., Trabucchi, M., & Frisoni, G. B. (1999) · Neurology · doi:10.1212/wnl.53.8.1825 · Cited by 155 · see citing works

LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease

Dodson, S. E., Gearing, M., Lippa, C. F., Montine, T. J., Levey, A. I., & Lah, J. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000228205.19915.20 · Cited by 151 · see citing works

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

Swerdlow, R. H., Parks, J. K., Davis, J. N., Cassarino, D. S., Trimmer, P. A., Currie, L. J., Dougherty, J., Bridges, W. S., Bennett, J. P., Wooten, G. F., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440605 · Cited by 148 · see citing works

Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance

Edland, S. D., Silverman, J. M., Peskind, E. R., Tsuang, D., Wijsman, E., & Morris, J. C. (1996) · Neurology · doi:10.1212/wnl.47.1.254 · Cited by 145 · see citing works

ole of apoE/Aβ Interactions in the Pathogenesis of Alzheimer's Disease and Cerebral Amyloid Angiopathy

Holtzman, D. M. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:147 · Cited by 143 · see citing works

The Association Between Genetic Variants in SORL1 and Alzheimer Disease in an Urban, Multiethnic, Community-Based Cohort

Lee, J. H., Cheng, R., Schupf, N., Manly, J. J., Lantigua, R., Stern, Y., Rogaeva, E. A., Wakutani, Y., Farrer, L. A., George‐Hyslop, P. S., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.501 · Cited by 143 · see citing works

Current and future uses of neuroimaging for cognitively impaired patients

Small, G. W., Bookheimer, S. Y., Thompson, P. M., Cole, G. M., Huang, S.-C., Kepe, V., & Barrio, J. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70019-x · Cited by 142 · see citing works

Presenilin-dependent Processing and Nuclear Function of γ-Protocadherins

Haas, I. G., Frank, M., Véron, N., & Kemler, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412909200 · Cited by 141 · see citing works

Microsatellite repeat instability and neurological disease

Brouwer, J. R., Willemsen, R., & Oostra, B. A. (2009) · BioEssays · doi:10.1002/bies.080122 · Cited by 137 · see citing works

Alzheimer's disease

Duara, R., Barker, W., Lopez-Alberola, R., Loewenstein, D., Grau, L. B., Gilchrist, D. M., Sevush, S., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.6.1575 · Cited by 132 · see citing works

Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.

Silverman, D. H. S., Gambhir, S. S., Huang, H.-W. C., Schwimmer, J., Kim, S., Small, G. W., Chodosh, J., Czernin, J. G., & Phelps, M. E. (2002) · PubMed · Cited by 131 · see citing works

Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies

Swerdlow, R. H. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21167 · Cited by 128 · see citing works

Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population.

Chagnon, P., Gee, M., Filion, M., Robitaille, Y., Belouchi, M., & Gauvreau, D. (1999) · American journal of medical genetics · doi:10.1002/(sici)1096-8628(19990702)85:1 · Cited by 128 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

Alzheimer's disease in Finnish twins

Räihä, I. J., Rajala, T., Sourander, L., Kaprio, J. A., & Koskenvuo, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91272-6 · Cited by 123 · see citing works

A comparison of familial and sporadic Alzheimer's disease

Duara, R., Lopez-Alberola, R. F., Barker, W. W., Loewenstein, D. A., Zatinsky, M., Eisdorfer, C. E., & Weinberg, G. B. (1993) · Neurology · doi:10.1212/wnl.43.7.1377 · Cited by 122 · see citing works

Mitochondrial DNA polymorphisms as risk factors for Parkinson?s disease and Parkinson?s disease dementia

Finnil�, S., Autere, J. M., Moilanen, J. S., Soininen, H. S., Mannermaa, A., Hartikainen, P., Hallikainen, M., & Majamaa, K. (2004) · Human Genetics · doi:10.1007/s00439-004-1123-9 · Cited by 120 · see citing works

Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length

Kehoe, P. G., Krawczak, M., Harper, P. S., Owen, M. J., & Jones, A. L. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.2.108 · Cited by 118 · see citing works

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

Koivunen, J., Verkkoniemi, A., Aalto, S., Paetau, A. E., Ahonen, J.-P., Viitanen, M. H., Någren, K., Rokka, J., Haaparanta‐Solin, M., Kalimo, H., et al. (2008) · Brain · doi:10.1093/brain/awn107 · Cited by 117 · see citing works

Evidence for an association between KIBRA and late-onset Alzheimer's disease

Corneveaux, J. J., Liang, W. S., Reiman, E. M., Webster, J., Myers, A., Zismann, V., Joshipura, K. D., Pearson, J. V., Hu‐Lince, D., Craig, D. W., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.014 · Cited by 112 · see citing works

Alzheimer's Disease

Bothwell, M. A., & Giniger, E. (2000) · Cell · doi:10.1016/s0092-8674(00)00032-5 · Cited by 108 · see citing works

Functional Alterations in Alzheimer's Disease: Selective Loss of Mitochondrial-encoded Cytochrome Oxidase mRNA in the Hippocampal Formation

Simonian, N. A., & Hyman, B. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00010 · Cited by 108 · see citing works

Cybrids in Alzheimer's disease: A cellular model of the disease?

Schon, E. A., Shoubridge, E. A., & Moraes, C. T. (1998) · Neurology · doi:10.1212/wnl.51.1.326 · Cited by 101 · see citing works

Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein

Hevner, R., & Wong-Riley, M. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-07-01942.1991 · Cited by 100 · see citing works

Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter

Furlong, R. A., Ho, L. W., Rubinsztein, J. S., Walsh, C., Paykel, E. S., & Rubinsztein, D. C. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4 · Cited by 100 · see citing works

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people

Bennett, D. A. (2005) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp.2004.054445 · Cited by 99 · see citing works

Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population

Huerta, C., Castro, M. G., Coto, E., Estrada, M. B., Ribacoba, R., Guisasola, L. M., Salvador, C., Martínez, C., Lahoz, C. H., & Álvarez, V. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.04.016 · Cited by 96 · see citing works

Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease.

Chandrasekaran, K., Hatanpaa, K., Rapoport, S., & Brady, D. (1997) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(96)00191-x · Cited by 95 · see citing works

KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment

Almeida, O. P., Schwab, S. G., Lautenschlager, N. T., Morar, B., Greenop, K. R., Flicker, L. A., & Wildenauer, D. B. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00229.x · Cited by 94 · see citing works

Maternal inheritance in Parkinson's disease

Wooten, G. F., Currie, L. J., Bennett, J. P., Harrison, M. B., Trugman, J. M., & Parker, W. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410218 · Cited by 93 · see citing works

Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases

Egensperger, R., Kösel, S., Schnopp, N. M., Mehraein, P., & Graeber, M. B. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01301.x · Cited by 90 · see citing works

Point Mutations of the mtDNA Control Region in Normal and Neurodegenerative Human Brains

Chinnery, P. F., Taylor, G. A., Howell, N., Brown, D. T., Parsons, T. J., & Turnbull, D. M. (2001) · The American Journal of Human Genetics · doi:10.1086/318204 · Cited by 88 · see citing works

Association between SORL1 and Alzheimer's disease in a genome-wide study

Meng, Y., Lee, J. H., Cheng, R., George‐Hyslop, P. S., Mayeux, R. P., & Farrer, L. A. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f13e7a · Cited by 86 · see citing works

Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem

Swerdlow, R. H. (2007) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81 · see citing works

Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients

Curti, D., Rognoni, F., Gasparini, L., Cattaneo, A., Paolillo, M., Racchi, M., Zani, L., Bianchetti, A., Trabucchi, M., Bergamaschi, S., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00741-6 · Cited by 80 · see citing works

Variability of Familial Risk of Alzheimer Disease Across the Late Life Span

Silverman, J. M., Ciresi, G., Smith, C. J., Marin, D. B., & Beeri, M. S. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.5.565 · Cited by 80 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Silverman, J. M., Raiford, K., Edland, S. D., Fillenbaum, G. G., Morris, J. C., Clark, C. M., Kukull, W. A., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.7.1253 · Cited by 77 · see citing works

State-specific projections through 2025 of Alzheimer disease prevalence

Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D., & Evans, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000123018.01306.10 · Cited by 77 · see citing works

Clinical features and genetics of myoclonic epilepsy with ragged red fibers.

DiMauro, S., Hirano, M., Kaufmann, P., Tanji, K., Sano, M. C., Shungu, D. C., Bonilla, E., & Vivo, D. C. D. (2002) · PubMed · Cited by 76 · see citing works

Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk

Rodríguez‐Rodríguez, E., Infante, J., Llorca, J., Mateo, I., Sánchez‐Quintana, C., García‐Gorostiaga, I., Sánchez‐Juan, P., Berciano, J., & Combarros, O. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.003 · Cited by 75 · see citing works

Hormonal imprinting: phylogeny, ontogeny, diseases and possible role in present‐day human evolution

Csaba, G. (2007) · Cell Biochemistry and Function · doi:10.1002/cbf.1412 · Cited by 71 · see citing works

Evidence for parent of origin effect in late-onset Alzheimer disease

Bassett, S. S., Avramopoulos, D., & Fallin, D. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10648 · Cited by 66 · see citing works

Carbon 11–Labeled Pittsburgh Compound B Positron Emission Tomographic Amyloid Imaging in Patients With APP Locus Duplication

Remes, A. M., Laru, L., Tuominen, H. J., Aalto, S., Kemppainen, N. M., Mononen, H., Någren, K., Parkkola, R. K., & Rinne, J. O. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.540 · Cited by 63 · see citing works

Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease

Cuenco, K. T. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1640 · Cited by 61 · see citing works

Sex of parent transmission effect in Tourette's syndrome

Eapen, V., O’Neill, J., Gurling, H., & Robertson, M. M. (1997) · Neurology · doi:10.1212/wnl.48.4.934 · Cited by 60 · see citing works

Gender ratio differences between Parkinson's disease patients and their affected relatives

Swerdlow, R. H., Parker, W. D., Currie, L. J., Bennett, J. P., Harrison, M., Trugman, J. M., & Wooten, G. F. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00029-8 · Cited by 58 · see citing works

The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients

Botta, A., Rinaldi, F., Catalli, C., Vergani, L., Bonifazi, E., Romeo, V., Loro, E., Viola, A., Angelini, C. I., & Novelli, G. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058909 · Cited by 56 · see citing works

Apolipoprotein E Dose-Dependent Modulation of β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease

DeMattos, R. B. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:255 · Cited by 55 · see citing works

Molecular Genetic Characterisation of Frontotemporal Dementia on Chromosome 3

Ashworth, A., Lloyd, S. E., Brown, J., Gydesen, S., Sorensen, S. A., Brun, A. E., Englund, E. M., Humphreys, C., Housman, D. E., Badura, M., et al. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051222 · Cited by 54 · see citing works

Diagnosis and management of MELAS

Thambisetty, M., & Newman, N. J. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.5.631 · Cited by 51 · see citing works

Variability of age at onset in siblings with familial Alzheimer disease

Gómez-Tortosa, E., Barquero, M. S., Barón, M., Sainz, M. J., Manzano, S., Payno, M., Ros, R., Almaraz, C., Gómez-Garré, P., & Jiménez-Escrig, A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1743 · Cited by 47 · see citing works

No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant

Wragg, M. A., Talbot, C. J., Morris, J. C., Lendon, C. L., & Goate, A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12146-3 · Cited by 44 · see citing works

Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy

Pal, D. K., Durner, M., Klotz, I., Dicker, E., Shinnar, S., Resor, S. R., Cohen, J., Harden, C. L., Moshé, S. L., Ballaban‐Gil, K. R., et al. (2006) · Brain and Development · doi:10.1016/j.braindev.2005.05.009 · Cited by 43 · see citing works

The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy.

Maceluch, J., & Niedziela, M. (2007) · PubMed · Cited by 42 · see citing works

A Novel Mitochondrial DNA Point Mutation in the tRNAIleGene Is Associated with Progressive External Ophtalmoplegia

Silvestri, G., Servidei, S., Rana, M., Ricci, E., Spinazzola, A., Paris, E., & Tonali, P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0453 · Cited by 42 · see citing works

The construction of viable nuclear-cytoplasmic hybrid cells by nuclear transplantation

Lucas, J. J., & Kates, J. R. (1976) · Cell · doi:10.1016/0092-8674(76)90169-0 · Cited by 41 · see citing works

Influence of SORL1 gene variants: Association with CSF amyloid-β products in probable Alzheimer's disease

Kölsch, H., Jessen, F., Wiltfang, J., Lewczuk, P., Dichgans, M., Kornhuber, J., Frölich, L., Heuser, I., Peters, O., Schulz, J. B., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.049 · Cited by 40 · see citing works

Predictors of progression in patients with Friedreich ataxia

Pean, A. L., Jeffries, N. O., Grow, C., Ravina, B. M., & Prospero, N. A. D. (2008) · Movement Disorders · doi:10.1002/mds.22248 · Cited by 40 · see citing works

Conjugal Alzheimer Disease

Jayadev, S., Steinbart, E. J., Chi, Y.-Y., Kukull, W. A., Schellenberg, G. D., & Bird, T. D. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.61 · Cited by 40 · see citing works

7 Mechanisms of Genomic Imprinting in Mammals

Cold, J. D., & Pedersen, R. A. (1994) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60552-9 · Cited by 37 · see citing works

Common variation inGRB-associated Binding Protein 2 (GAB2)and increased risk for Alzheimer dementia

Sleegers, K., Bettens, K., Brouwers, N., Engelborghs, S., Miegroet, H. V., Deyn, P. P. D., & Broeckhoven, C. V. (2008) · Human Mutation · doi:10.1002/humu.20909 · Cited by 36 · see citing works

Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues

Mandel, J., & Biancalana, V. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.034 · Cited by 32 · see citing works

Differential Chromosome Sensitivity to 5-Azacytidine in Alzheimer’s Disease

Payão, S. L. M., Smith, M. D. A. C., & Bertolucci, P. H. F. (1998) · Gerontology · doi:10.1159/000022023 · Cited by 22 · see citing works

Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease.

Kirchner, S. C., Hallagan, S. E., Farin, F. M., Dilley, J. A., Costa‐Mallen, P., Smith‐Weller, T., Franklin, G. M., Swanson, P. D., & Checkoway, H. (2000) · PubMed · Cited by 20 · see citing works

Alzheimer's disease: advances in trafficking

Mayeux, R., & Hyslop, P. S. G. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70298-3 · Cited by 20 · see citing works

Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190

Hh, G., Saito, K., Klaman, L. D., Jq, S., Fleming, T., Wang, Y., Pratt, J. C., Lin, G., Lim, B., Kinet, J., et al. (2001) · Cited by 20 · see citing works

Possible Association between SORL1 and Alzheimer Disease?

Lee, J. H., Shibata, N., Cheng, R., & Mayeux, R. P. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000167792 · Cited by 16 · see citing works

Conjugal Alzheimer's disease: Is there an increased risk in offspring?

Bird, T. D., Nemens, E. J., & Kukull, W. A. (1993) · Annals of Neurology · doi:10.1002/ana.410340315 · Cited by 16 · see citing works

The increasingly complex genetics of Tourette's syndrome

Sadovnick, A. D., & Kurlan, R. (1997) · Neurology · doi:10.1212/wnl.48.4.801 · Cited by 16 · see citing works

A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C‐peptide secretion, HLA‐DR and ‐DQ status and autoantibody pattern

Hosszúfalusi, N., Karcagi, V., Horváth, R., Palik, É., Várkonyi, J., Rajczy, K., Prohászka, Z., Szentirmai, C., Karádi, I., Romics, L., et al. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.841 · Cited by 12 · see citing works

Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease

Mackenzie, I. R., Butland, S. L., Devon, R. S., Dwosh, E., Feldman, H., Lindholm, C., Neal, S. J., Ouellette, B. F. F., & Leavitt, B. R. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-32 · Cited by 7 · see citing works

Movement disorders: insights into mechanisms and hopes for treatment

Wider, C. W., & Wszołek, Z. K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70273-4 · Cited by 4 · see citing works

Untitled work

Price (1999) · doi:10.1002/1531-8249(199903)45:3

Untitled work

Khan (2000) · doi:10.1002/1531-8249(200008)48:2

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.

Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274 · see citing works

The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · see citing works

The biological pathways of Alzheimer disease: a review

Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 271 · see citing works

Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease

Swerdlow, R. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4149 · Cited by 203 · see citing works

Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis

Hu, G., Niu, F., Humburg, B. A., Liao, K., Bendi, V. S., Callen, S. E., Fox, H. S., & Buch, S. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24307 · Cited by 196 · see citing works

Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia

Uddin, M. S., Rahman, M. M., Jakaria, M., Rahman, M. S., Hossain, M. S., Islam, A., Ahmed, M., Mathew, B., Omar, U. M., Barreto, G. E., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01911-8 · Cited by 156 · see citing works

Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review

Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Bringas-Vega, M. L., García-del-Barco-Herrera, D., Berlanga-Saez, J. O., Ojalvo, A. G., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560375 · Cited by 139 · see citing works

Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease

Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138 · see citing works

Maternal e-cigarette exposure results in cognitive and epigenetic alterations in offspring in a mouse model

Nguyen, T., Li, G. E., Chen, H., Cranfield, C. G., McGrath, K. C., & Gorrie, C. A. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00084 · Cited by 135 · see citing works

Autophagy Dysfunction in Alzheimer’s Disease: Mechanistic Insights and New Therapeutic Opportunities

Di Meco, A., Curtis, M. E., Lauretti, E., & Praticò, D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.008 · Cited by 133 · see citing works

Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease

Zhao, L., Mao, Z., Woody, S. K., & Brinton, R. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.011 · Cited by 132 · see citing works

Mitochondria, Cybrids, Aging, and Alzheimer's Disease

Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106 · see citing works

Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration

Wilkins, H. M., Weidling, I. W., Ji, Y., & Swerdlow, R. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00508 · Cited by 102 · see citing works

Relative risk for Alzheimer disease based on complete family history

Cannon‐Albright, L., Foster, N. L., Schliep, K. C., Farnham, J. M., Teerlink, C. C., Kaddas, H. K., Tschanz, J. T., Corcoran, C., & Kauwe, J. S. K. (2019) · Neurology · doi:10.1212/wnl.0000000000007231 · Cited by 100 · see citing works

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease

Honea, R. A., Swerdlow, R. H., Vidoni, E. D., & Burns, J. M. (2011) · Neurology · doi:10.1212/wnl.0b013e31820e7b74 · Cited by 99 · see citing works

Estrogen receptor β in Alzheimer’s disease: From mechanisms to therapeutics

Zhao, L., Woody, S. K., & Chhibber, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.08.001 · Cited by 97 · see citing works

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease

Mosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., McHugh, P., & Swerdlow, R. H. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110866 · Cited by 97 · see citing works

Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility

Qureshi, I., & Mehler, M. F. (2010) · Progress in brain research · doi:10.1016/b978-0-444-53630-3.00006-3 · Cited by 94 · see citing works

Mitochondrial Abnormalities in Alzheimer’s Disease

Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86 · see citing works

Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatment

Pahnke, J., Langer, O., & Krohn, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.001 · Cited by 81 · see citing works

Maternal family history is associated with Alzheimer's disease biomarkers

Honea, R. A., Initiative, F. T. A. D. N., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120676 · Cited by 79 · see citing works

Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort

Study, F. T. A., Salvadó, G., Brugulat‐Serrat, A., Sudre, C. H., Grau‐Rivera, O., Suárez‐Calvet, M., Falcón, C., Fauria, K., Cardoso, M. J., Barkhof, F., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0460-1 · Cited by 71 · see citing works

Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents

Mosconi, L., Rinne, J. O., Tsui, W. H., Murray, J., Li, Y., Glodzik, L., McHugh, P. F., Williams, S., Cummings, M., Pirraglia, E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.002 · Cited by 67 · see citing works

Influence of family history of dementia in the development and progression of late‐onset Alzheimer's disease

Scarabino, D., Gambina, G., Broggio, E., Pelliccia, F., & Corbo, R. M. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32399 · Cited by 62 · see citing works

Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis

Scheffler, K., Krohn, M., Dunkelmann, T., Stenzel, J., Miroux, B., Ibrahim, S. M., Halbach, O. V. B. U., Heinze, H., Walker, L. C., Gsponer, J. A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0980-x · Cited by 61 · see citing works

Parental family history of dementia in relation to subclinical brain disease and dementia risk

Wolters, F. J., van der Lee, S. J., Koudstaal, P. J., van Duijn, C. M., Hofman, A., Ikram, M. K., Vernooij, M. W., & Ikram, M. A. (2017) · Neurology · doi:10.1212/wnl.0000000000003871 · Cited by 59 · see citing works

Structural brain changes in normal individuals with a maternal history of Alzheimer's

Berti, V., Mosconi, L., Glodzik, L., Li, Y., Murray, J., De Santi, S., Pupi, A., Tsui, W., & De Leon, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.001 · Cited by 58 · see citing works

Mitochondria, Amyloid β, and Alzheimer′s Disease

Readnower, R. D., Sauerbeck, A. D., & Sullivan, P. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/104545 · Cited by 55 · see citing works

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi, L., & McHugh, P. F. (2011) · PubMed · Cited by 53 · see citing works

Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD

Mosconi, L., Murray, J., Tsui, W. H., Li, Y., Spector, N. C., Goldowsky, A. M., Williams, S., Osorio, R. S., McHugh, P. F., Glodzik, L., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000181 · Cited by 51 · see citing works

Mitochondrial Genomic Analysis of Late Onset Alzheimer’s Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging

Ridge, P. G., Maxwell, T. J., Corcoran, C. D., Norton, M. C., Tschanz, J. T., O’Brien, E., Kerber, R. A., Cawthon, R., Munger, R. G., & Kauwe, J. S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045134 · Cited by 52 · see citing works

Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease

Berti, V., Polito, C., Lombardi, G., Ferrari, C., Sorbi, S., & Pupi, A. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2477-1 · Cited by 51 · see citing works

Decreased Recall of Primacy Words Predicts Cognitive Decline

Bruno, D., Reiss, P. T., Petkova, E., Sidtis, J. J., & Pomara, N. (2013) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acs116 · Cited by 49 · see citing works

Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease

Duarte, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.044 · Cited by 48 · see citing works

Energy and the Alzheimer brain

Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 46 · see citing works

Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's

Mosconi, L., Glodzik, L., Mistur, R., McHugh, P., Rich, K. E., Javier, E., Williams, S., Pirraglia, E., De Santi, S., Mehta, P. D., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.011 · Cited by 46 · see citing works

Comparing Brain Amyloid Deposition, Glucose Metabolism, and Atrophy in Mild Cognitive Impairment with and without a Family History of Dementia

Mosconi, L., Initiative, A. D. N., Andrews, R. D., & Matthews, D. C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121867 · Cited by 43 · see citing works

Mitochondria and Alzheimer's disease

Piaceri, I., Rinnoci, V., Bagnoli, S., Failli, Y., & Sorbi, S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.033 · Cited by 40 · see citing works

Sex‐specific accelerated decay in time/activity‐dependent plasticity and associative memory in an animal model of Alzheimer's disease

Navakkode, S., Gaunt, J. R., Pavón, M. V., Bansal, V. A., Abraham, R. P., Chong, Y. S., Ch’ng, T. H., & Sajikumar, S. (2021) · Aging Cell · doi:10.1111/acel.13502 · Cited by 39 · see citing works

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease

Murray, J., Tsui, W. H., Li, Y., McHugh, P. F., Williams, S., Cummings, M., Pirraglia, E., Sólnes, L. B., Osorio, R. S., Glodzik, L., et al. (2014) · Advances in Molecular Imaging · doi:10.4236/ami.2014.42003 · Cited by 39 · see citing works

Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases

H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35 · see citing works

Using Biomarkers to Improve Detection of Alzheimer’s Disease

Biagioni, M. C., & Galvin, J. E. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.11 · Cited by 34 · see citing works

New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34 · see citing works

Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice

Shang, Y., Mishra, A., Wang, T., Wang, Y., Desai, M. K., Chen, S., Mao, Z., Do, L., Bernstein, A. S., Trouard, T. P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225392 · Cited by 36 · see citing works

Alcohol-induced blackouts and maternal family history of problematic alcohol use

Marino, E. N., & Fromme, K. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.01.043 · Cited by 32 · see citing works

Executive functioning and risk for Alzheimer’s disease in the cognitively intact: Family history predicts Wisconsin Card Sorting Test performance.

Hazlett, K. E., Figueroa, C. M., & Nielson, K. A. (2015) · Neuropsychology · doi:10.1037/neu0000181 · Cited by 33 · see citing works

Impaired mitochondrial energy production and ABC transporter function—A crucial interconnection in dementing proteopathies of the brain

Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 32 · see citing works

PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease

Fleck, D., Phu, L., Verschueren, E., Hinkle, T. B., Reichelt, M., Bhangale, T., Haley, B., Wang, Y., Graham, R., Kirkpatrick, D. S., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-19.2019 · Cited by 31 · see citing works

Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model

Wang, T., Yao, J., Chen, S., Mao, Z., & Brinton, R. D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00793-6 · Cited by 28 · see citing works

Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome

Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 26 · see citing works

White matter fiber density abnormalities in cognitively normal adults at risk for late-onset Alzheimer's disease.

Sánchez, S., Duarte-Abritta, B., Abulafia, C., Pino, G. D., Bocaccio, H., Castro, M., Sevlever, G., Fonzo, G., Nemeroff, C., Gustafson, D., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.12.019 · Cited by 20 · see citing works

Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations

Mani, S., Swargiary, G., Singh, M., Agarwal, S., Dey, A., Ojha, S. K., & Jha, N. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119985 · Cited by 23 · see citing works

Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring

Stroh, M. A., Swerdlow, R. H., & Zhu, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.022 · Cited by 20 · see citing works

Maternal imprinting on cognition markers of wild type and transgenic Alzheimer’s disease model mice

Zamarbide, M., Gil-Bea, F. J., Bannenberg, P., Martínez‐Pinilla, E., Sandoval, J., Franco, R., & Pérez‐Mediavilla, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-24710-7 · Cited by 17 · see citing works

Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease

Duarte-Abritta, B., Villarreal, M. F., Abulafia, C., Loewenstein, D., Curiel, R. E., Castro, M. N., Surace, E. I., Sánchez, S. M., Vigo, D. E., Vázquez, S., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.10.008 · Cited by 17 · see citing works

Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease

Mosconi, L., Tsui, W., Murray, J., McHugh, P. F., Li, Y., Williams, S., Pirraglia, E., Glodzik, L., Santi, S. D., Vallabhajosula, S., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.003 · Cited by 16 · see citing works

Gestational high fat diet protects 3xTg offspring from memory impairments, synaptic dysfunction, and brain pathology

Meco, A. D., Jelı́nek, J., Lauretti, E., Curtis, M. E., Issa, J. J., & Praticò, D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0489-y · Cited by 14 · see citing works

Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice

Kapadia, M., Mian, M. F., Ma, D., Hutton, C. P., Azam, A., Narkaj, K., Cao, C., Brown, B., Michalski, B., Morgan, D., et al. (2021) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-020-00745-9 · Cited by 14 · see citing works

Offspring Study of Racial and Ethnic Disparities in Alzheimer’s Disease: Objectives and DesignPreprint

Manly, J. J., Rentería, M. A., Avila‐Rieger, J. F., Turney, I. C., Vonk, J. M. J., Lao, P. J., Šeblová, D., Fleurimont, J., Martinez, M. N., & Brickman, A. M. (2020) · doi:10.31234/osf.io/frbkj · Cited by 14 · see citing works

Maternal Transmission of Alzheimer Disease

Heggeli, K., Crook, J. E., Thomas, C. S., & Graff‐Radford, N. R. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318247d203 · Cited by 13 · see citing works

The concept of FDG-PET endophenotype in Alzheimer’s disease

During, E., Osorio, R. S., Elahi, F. M., Mosconi, L., & de Leon, M. J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0633-1 · Cited by 11 · see citing works

Mild Cognitive Impairment, Risk Factors and Magnetic Resonance Volumetry: Role of Probable Alzheimer's Disease in the Family

Rogne, S., Vangberg, T. R., Eldevik, P., Wikran, G., Mathiesen, E. B., & Schirmer, H. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000350408 · Cited by 11 · see citing works

Plant-derived compounds, vitagens, vitagenes and mitochondrial function

Franco, R., Navarro, G., & Martínez‐Pinilla, E. (2022) · PharmaNutrition · doi:10.1016/j.phanu.2021.100287 · Cited by 8 · see citing works

Mitochondria Specific Antioxidants and their Derivatives in the Context of the Drug Development for Neurodegeneration and Cancer

Aliev, G. M., Palacios, H. H., & Cacabelos, P. (2012) · Drug Designing Open Access · doi:10.4172/2169-0138.1000103 · Cited by 8 · see citing works

Long‐term trajectories and current BMI are associated with poorer cognitive functioning in middle‐aged adults at high Alzheimer's disease risk

West, R. K., Ravona‐Springer, R., Sharvit‐Ginon, I., Ganmore, I., Manzali, S., Tirosh, A., Golan, S., Boccara, E., Heymann, A. D., & Beeri, M. S. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12247 · Cited by 8 · see citing works

Antioxidant modulation in restoring mitochondrial function in neurodegeneration

Arrozi, A. P., Ngah, W. Z. W., Yusof, Y. A. M., Damanhuri, H. A., & Makpol, S. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1178261 · Cited by 6 · see citing works

Oculomotor Abnormalities during Reading in the Offspring of Late-Onset Alzheimer’s Disease

Fernández, G., González, A. P., Abulafia, C., Fiorentini, L., Agamennoni, O. E., & Guinjoan, S. M. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220413075840 · Cited by 5 · see citing works

Mitochondrial DNA and Alzheimer’s disease: a first case–control study of the Tunisian population

Salem, N. B., Boussetta, S., de Rojas, I., Moreno–Grau, S., Montrreal, L., Mokni, N., Mahmoud, I., Younes, S., Daouassi, N., Frih-Ayed, M., et al. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06978-7 · Cited by 5 · see citing works

Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study

Dingle, S. E., Milte, C. M., Daly, R. M., & Torres, S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230176 · Cited by 5 · see citing works

Exploring first-degree family history in a cohort of Portuguese Alzheimer’s disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors

Tábuas‐Pereira, M., Bernardes, C., Durães, J., Lima, M., Nogueira, A. R., Saraiva, J. R., Tábuas, T., Coelho, M., Paquette, K., Westra, K., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12673-x · Cited by 3 · see citing works

Editorial: Metabolism in Alzheimer's Disease

Morris, J. K., Wood, L. B., & Wilkins, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.824145 · Cited by 3 · see citing works

Mitochondrial Function and Neurodegenerative Diseases

Wilkins, H. M., Weidling, I., Koppel, S., Wang, X., von Schulze, A., & Swerdlow, R. H. (2018) · The Molecular and Cellular Basis of Neurodegenerative Diseases · doi:10.1016/b978-0-12-811304-2.00013-4 · Cited by 2 · see citing works

Maternal imprinting, mitochondrial DNA, nuclear DNA and Alzheimer’s disease

Pérez‐Mediavilla, A., & Zamarbide, M. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00010 · Cited by 2 · see citing works

Individual cognitive and depressive traits associated with maternal versus paternal family history of Late-onset Alzheimer’s disease: Proactive semantic interference versus standard neuropsychological assessments

Wilson, K. E., Abulafia, C., Loewenstein, D., Vigo, D. E., Sevlever, G. E., Nemeroff, C. B., Villarreal, M. F., & Guinjoan, S. M. (2018) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2018.09.002 · Cited by 2 · see citing works

Transcriptional Coordination between Mitochondrial and Nuclear Genomes for Oxidative Phosphorylation Is Disrupted in Alzheimer’s BrainPreprint

Shang, Y., Yin, F., & Brinton, R. D. (2022) · Research Square · doi:10.21203/rs.3.rs-2122232/v1 · Cited by 1 · see citing works

S-Equol, a Metabolite of Soy Daidzein, and Cognitive Function

Jackson, R. L., Greiwe, J. S., & Schwen, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00094-x

A characterization of deficits associated with loss of NCB5OR in the mouse brain

Stroh, M. A. (2016) · KU ScholarWorks (The University of Kansas)

Extended Maternal and Paternal Hereditary Risk for Alzheimer’s Disease Examined by Sex in a Sample of Community Dwelling Older Adults in Cache County, Utah

Vernon, E. K. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/6047-aa65

Ketotherapeutics to Rescue Brain Energy Deficits

Myette‐Côté, É., Castellano, C., Fortier, M., St‐Pierre, V., & Cunnane, S. C. (2022) · doi:10.1093/med/9780197501207.003.0017

Mitochondrial DNA and Alzheimer's Disease: A First Case-control Study of the Tunisian PopulationPreprint

Salem, N. B., Boussetta, S., de Rojas, I., Moreno–Grau, S., Montrreal, L., Mokni, N., Mahmoud, I., Younes, S., Daouassi, N., Frih-Ayed, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1036952/v1

Novel Treatment for Alzheimer’s Disease: Tapping the Somatostatin-evoked Aβ Catabolism via α-endosulfine-KATP Channel Pathway

Varghese, R., Digholkar, G., Deshpande, A., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010013 · Cited by 1 · see citing works

Additional file 1 of Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice

Kapadia, M., Mian, M. F., Ma, D., Hutton, C. P., Azam, A. B., Narkaj, K., Cao, C., Brown, B., Michalski, B., Morgan, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13619932

Body mass index decline and cognitive trajectories in mild cognitive impairment: the role of maternal history of Alzheimer’s diseasePreprint

Hernández, A. P., González‐Dávila, E., & Norberto, R.-E. (2026) · Research Square · doi:10.21203/rs.3.rs-9696646/v1

Using machine learning of neuroimaging and mitochondrial haplogroups to predict maternal family history of Alzheimer’s disease

Veatch, O. J., Dutta, S., Mansel, C. O., Townley, R., Sardiu, M. E., & Honea, R. A. (2026) · PLOS Aging and Health · doi:10.1371/journal.page.0000045

Brain Hypometabolism, Oxidative Stress, Maternal Transmission, and Risk of Late-Onset Alzheimer’s Disease

Mosconi, L., Murray, J., McHugh, P. F., & de Leon, M. J. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_10

Maternal transmission of Alzheimer’s disease: Prodromal metabolic phenotype

(2016)

P1‐329: Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease

Murray, J., Mosconi, L., Tsui, W., McHugh, P. F., Williams, S., Pirraglia, E., Cummings, M., Glodzik, L., Santi, S. D., Vallabhajosula, S., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.609

Brain Hypometabolism, Oxidative Stress, Maternal Transmission, and Risk of Late-Onset Alzheimer’s Disease

Mosconi, L., Murray, J., McHugh, P. F., & de Leon, M. J. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_10

P1‐269: Maternal history of Alzheimer's disease predisposes to progressive brain hypometabolism on FDG‐PET

Mosconi, L., Mistur, R. L., Bryś, M., Glodzik, L., Switalski, R., Pirraglia, E., Rich, K. E., Tsui, W., & de Leon, M. J. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.859

Mom and me

DHAWAN, V. M., & Eidelberg, D. (2009) · Neurology · doi:10.1212/01.wnl.0000341939.31303.32